Terms ending in 2039
Every in-force patent on Codiak Biosciences, Inc.'s record whose computed term ends in 2039, whoever holds it now. Soonest term end first, then patent number.
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 11,512,315 | Methods and Compositions for Macrophage Polarization In force · High confidence | Lonza Sales AG | In force | High confidence | |
| US 12,570,978 | Methods and Compositions for Macrophage Polarization In force · High confidence | Lonza Sales AG | In force | High confidence | |
| US 12,066,382 | Methods of Measuring Extracellular Vesicles and Nanoparticles in Complex Matrices by Light Scattering In force · High confidence | Lonza Sales AG | In force | High confidence |
3 of 3 patents shown. Soonest term end first, then patent number.
1 of these is in force and held by Codiak Biosciences, Inc..
Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.